Joseph H. Reilly
CIK 1610499 · View on SEC EDGAR ↗
First SEC filing: July 9, 2014 · Latest: July 9, 2014
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2020 | NERV | S | 3,228 | $2.64 | $8,522 | 31,747 Direct | -9.23% | Disposed | -76.5% (price as of 2026-08-21) |
| Dec. 17, 2019 | NERV | S | 2,724 | $7.10 | $19,340 | 26,225 Direct | -9.41% | Disposed | -91.3% (price as of 2026-08-21) |
| Dec. 17, 2018 | NERV | S | 2,728 | $7.46 | $20,351 | 20,199 Direct | -11.90% | Disposed | -91.7% (price as of 2026-08-21) |
| Oct. 1, 2018 | NERV | S 10b5-1 | 1,700 | $12.62 | $21,454 | 14,177 Direct | -10.71% | Disposed | -95.1% (price as of 2026-08-21) |
| Oct. 1, 2018 | NERV | S 10b5-1 | 23,300 | $12.02 | $280,066 | 15,877 Direct | -59.47% | Disposed | -94.8% (price as of 2026-08-21) |
| Aug. 23, 2018 | NERV | S 10b5-1 | 25,000 | $10.00 | $250,000 | 14,177 Direct | -63.81% | Disposed | -93.8% (price as of 2026-08-21) |
| Dec. 14, 2017 | NERV | S | 2,906 | $5.80 | $16,855 | 14,177 Direct | -17.01% | Disposed | -89.3% (price as of 2026-08-21) |
| Jan. 11, 2017 | NERV | S 10b5-1 | 1,600 | $12.03 | $19,248 | 8,333 Direct | -16.11% | Disposed | -94.8% (price as of 2026-08-21) |
| July 1, 2014 | NERV | P | 8,333 | $6.00 | $49,998 | 8,333 Direct | — | Acquired | -89.7% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 14, 2020 | NERV | Restricted Stock Unit | Common Stock (8,750) | — | — | 8,750 | Disposed |
| Oct. 13, 2020 | NERV | Employee Stock Option (right to buy) | Common Stock (85,000) | $3.50 | Oct. 12, 2030 | 85,000 | Acquired |
| June 19, 2020 | NERV | Employee Stock Option (right to buy) | Common Stock (153,531) | $7.11 | Dec. 31, 2029 | 153,531 | Acquired |
| Dec. 31, 2019 | NERV | Employee Stock Option (right to buy) | Common Stock (41,469) | $7.11 | Dec. 30, 2029 | 41,469 | Acquired |
| Dec. 14, 2019 | NERV | Restricted Stock Unit | Common Stock (8,750) | — | — | 8,750 | Disposed |
| Dec. 14, 2018 | NERV | Restricted Stock Unit | Common Stock (8,750) | — | — | 8,750 | Disposed |
| Dec. 11, 2018 | NERV | Employee Stock Option (right to buy) | Common Stock (120,000) | $7.96 | Dec. 10, 2028 | 120,000 | Acquired |
| Oct. 1, 2018 | NERV | Employee Stock Option (Right to Buy) | Common Stock (10,000) | $5.19 | April 13, 2025 | 10,000 | Disposed |
| Oct. 1, 2018 | NERV | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $4.71 | Dec. 3, 2025 | 15,000 | Disposed |
| Aug. 23, 2018 | NERV | Employee Stock Option (Right to Buy) | Common Stock (25,000) | $4.71 | Dec. 3, 2025 | 25,000 | Disposed |
| Dec. 14, 2017 | NERV | Restricted Stock Unit | Common Stock (8,750) | — | — | 8,750 | Disposed |
| Dec. 13, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock (120,000) | $6.10 | Dec. 13, 2027 | 120,000 | Acquired |
| Jan. 11, 2017 | NERV | Stock Option (Right to Buy) | Common Stock (1,600) | $4.71 | Dec. 3, 2025 | 1,600 | Disposed |
| Dec. 14, 2016 | NERV | Employee Stock Option (Right to Buy) | Common Stock (60,000) | — | Dec. 13, 2026 | 60,000 | Acquired |
| Dec. 14, 2016 | NERV | Restricted Stock Unit | Common Stock (35,000) | — | — | 35,000 | Acquired |
| Dec. 4, 2015 | NERV | Stock Option (right to buy) | Common Stock (69,000) | — | Dec. 3, 2025 | 69,000 | Acquired |
| April 14, 2015 | NERV | Stock Option (right to buy) | Common Stock (57,524) | — | April 13, 2025 | 57,524 | Acquired |
| June 30, 2014 | NERV | Employee Stock Option (Right to Buy) | Common Stock (93,541) | $6.00 | June 29, 2024 | 93,541 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 20, 2026 | NERV | Common Stock | 20,872 | Direct |
| Aug. 20, 2026 | NERV | Employee Stock Option (right to buy)→ Common Stock (10,625) | 10,625 | Direct |
| Aug. 20, 2026 | NERV | Employee Stock Option (right to buy)→ Common Stock (22,500) | 22,500 | Direct |
| Aug. 20, 2026 | NERV | Employee Stock Option (right to buy)→ Common Stock (27,000) | 27,000 | Direct |
| Aug. 20, 2026 | NERV | Employee Stock Option (right to buy)→ Common Stock (56,100) | 56,100 | Direct |
| Aug. 20, 2026 | NERV | Employee Stock Option (right to buy)→ Common Stock (47,500) | 47,500 | Direct |
| Aug. 20, 2026 | NERV | Employee Stock Option (right to buy)→ Common Stock (750,000) | 750,000 | Direct |
| Aug. 20, 2026 | NERV | Employee Stock Option (right to buy)→ Common Stock (680,000) | 680,000 | Direct |